Fabhalta and Vanrafia Phase III analyses, Fabhalta real-world treatment pattern data, and zigakibart Phase I/II trial showcase strength of IgA nephropathy (IgAN) portfolioC3 glomerulopathy (C3G) studi ...
Zoho has introduced a major update to its note-taking application, Zoho Notebook, adding advanced artificial intelligence (AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback